Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses-Reference-Cited by-同舟云学术

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses

Published:2020-01 Issue:1 Volume:222 Page:56.e1-56.e17
ISSN:0002-9378
Container-title:American Journal of Obstetrics and Gynecology
language:en
Short-container-title:American Journal of Obstetrics and Gynecology

Author:

Gentry-Maharaj Aleksandra,Burnell Matthew^ORCID,Dilley James,Ryan Andy,Karpinskyj Chloe,Gunu Richard,Mallett Susan,Deeks Jon,Campbell Stuart,Jacobs Ian,Sundar Sudha,Menon Usha^ORCID

Funder

National Institute for Health Research Health Technology Assessment grant

Refining Ovarian Cancer Test accuracy scores

National Institute for Health Research University College London Hospitals Biomedical Research Centre

Medical Research Council

United Kingdom Collaborative Trial of Ovarian Cancer Screening was core funded by the Medical Research Council

Cancer Research UK

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference33 articles.

1. ACOG Committee on Practice B-G. Evaluation and management of adnexal masses. CVOG Practice bulletin no. 174;Obstet Gynecol,2016

2. SIGN 135;Management of epithelial ovarian cancer—a national clinical guideline,2018

3. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer;Jacobs;Br J Obstet Gynaecol,1990

4. Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis Group;Timmerman;Am J Obstet Gynecol,2016

5. Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA study;Testa;Br J Cancer,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of serum CA125, HE4 and CA724 and the risk of ovarian malignancy algorithm score in the diagnosis of high-grade serous ovarian cancer;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-06

2. β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway;Molecular and Cellular Endocrinology;2024-03

3. O-RADS MRI scoring system has the potential to reduce the frequency of avoidable adnexal surgery;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-03

4. Derivation and validation of a nomogram based on clinical characteristics to diagnose endometriosis associated ovarian cancer preoperatively;Journal of Cancer Research and Clinical Oncology;2024-01

5. An ML-based decision support system for reliable diagnosis of ovarian cancer by leveraging explainable AI;Informatics in Medicine Unlocked;2024